Background: Although in Systemic Sclerosis (SSc) the cutaneous manifestations are the most noticeable features, lung involvement guides the disease prognosis. High resolution computed tomography (HRCT) is the mainstay for the detection of the interstitial lung disease (ILD). However, exposure to ionising radiation is a major limitation for the repetition of this examination. Over the last years, lung ultrasound (US) gained an intriguing potential in the evaluation of several pulmonary condition, and in previous studies was found a significant correlation between US score and HRCT score [1] . Objectives: To establish the cut-off point of the US B-lines number for detecting the presence of SSc-ILD. Methods: Patients with SSc-ILD underwent chest HRCT, lung US, pulmonary function test, and clinical assessment. Exclusion criteria were represented by the presence of a coexisting congestive heart failure and other lung or pleural diseases (i.e., pneumonia, pleural effusion). HRCT were scored for the presence of ILD by an experienced radiologist, in accordance with the Warrick method. US assessment was performed by a US skilled rheumatologist, blinded to the HRCT results, and included the bilateral evaluation of 14 lung intercostal spaces (LIS) [2] . In each LIS the number of B-lines was recorded and summed. To test discriminant validity we used the receiver operating characteristic (ROC) curve analysis applying a Warrick score of 7 as external criterion for the presence of SSc-ILD. Results: Forty patients completed the study. The US B-lines number and the Warrick score confirmed an excellent correlation (Spearman's rho: 0.819, p<0.001). The ROC curve analysis revealed that the presence of 10 US B-lines is the cut-off point with the greatest positive likelihood ratio (12.52) for the presence of SSc-ILD (Table) Background: Antisynthetase syndrome (ASSD) is an autoimmune disease characterized by the clinical triad arthritis, myositis, and interstitial lung disease (ILD). As in inflammatory myopathies, nailfold videocapillaroscopy (NVC) alterations have been sporadically described also in ASSD patients, but no elucidating data are available. Objectives: To investigate the possible specific NVC features of ASSD patients. Methods: Within the framework of a multicenter study, we retrospectively analyzed NVC images of ASSD patients, after excluding patients with overlap syndrome with systemic sclerosis. Two operators in a blind manner re-evaluated all patients with at least one image per finger. For each patient, we examined number of capillaries (mean number of capillaries per mm in the distal row), enlarged and giant capillaries, micro-hemorrhages, avascular areas, ramified capillaries, and the presence of a scleroderma (SSc)-like pattern, according to Manfredi et al. Finally, we correlated NVC features with clinical and serological findings of ASSD patients. Results: The NVC of 54 ASSD patients were analyzed (males/females 1/6.8, mean age 55.79, CI95% 51.9-59.9 years, mean disease duration 59.4, CI95% 27.9-90.9 months). Raynaud's phenomenon (RP) was recorded in 51.9% of patients, arthritis in 79.6%, myositis in 53.7%, and ILD in 92.6%. NVC alterations were observed in 53.7% of AASD patients. Nineteen patients (35.2%) showed a SSc-like pattern; the main features were disarrangement of hairpin and angiogenetic aspects (42.6%), avascular areas (38.9%), giant capillaries (27.6%), and microhemorrhages (20.4%). Finally, the mean number of capillaries was reduced (7.8±2/mm). No significant association was recorded between SSc-like pattern and the presence of arthritis, myositis, and ILD, nor with RP. Among other NVC features, angiogenesis was significantly associated to female gender (p=0.031), while microhemorrhages were inversely associated to the presence of arthritis (0.033). No association was observed between NVC features and autoantibodies profile. Of interest, in 58% of patients with ILD we observed at least a NVC alteration vs no patients without ILD (p=0.04). Finally, in patients with RP NVC alterations were recorded in 15/28 patients (53.6%) and a SSc-like pattern in 11/28 (39.3%), while only 57.9% of patients with SSc-like pattern had a clinically manifest Raynaud's phenomenon. Conclusions: Despite preliminary, the present is the first study concerning NVC in AASD patients. Regardless of the presence of Raynaud's phenomenon, NVC alterations are frequently observed; in particular, a SSc-like pattern is recorded in more than 1/3 of patients. NVC should be performed in all ASSD patients at diagnosis regardless of the presence of RP in the patient history and during follow-up. ASSD should be always considered in the screening of RP. A prospective multicenter study has been planned to identify specific patterns and possible associations between NVC findings and clinical and serological features of ASSD. ® questionarie was applied to evaluated gastrointestinal symptoms and classified in not symptomatic, least, mildy, moderately and most symptomatic. Glucose HBT was applied after 14 hours fast, oral hygiene and 30 days free of antibiotics. Patients who has a negative HBT with symptoms associated to glucose ingestion we repeat test with lactulose. Results: We applied questionnaire to 58 SSc patients, age 52 (26-75)years, 65 (96%) female and 3 (4%) males, disease duration 13 (1-40) years, limited SSc 41 (59%) and diffuse 27 (41%), body mass index 24 (12-39). They are using prednisone (28%), micofenolate (14%), methotrexate (19%), azatioprin (5%), amlodipine or nifedipine (33%). Patients had continuous and very high increase of parts per millon (ppm) of exhaled Hydrogen: min0: 13 ppm (5-21), min15:17 ppm (5-43), min30:17 (3-49), min45:18ppm (7-103), min 60:22ppm (8-145), min90:18ppm (2-250), min120:25ppm (3-212), min150:71ppm (3-235). Normal values: <10 ppm during total test (Figure1). Frequency of gastrointestinal symptoms were flatulence (87.5vs81.2%), nausea/vomiting (72.7vs37.6%), constipation (65.6vs40%), diarrhea (45.2vs33.4%), abdominal pain %) and incontinence (39.4vs31.3%) respectively between SCB (+) positive and negative. Hyperproduction of hydrogen in breath had a direct correlation to severity of their symptoms (p≤0.05). The severity of diarrhea was in close relation to the severity of its rectal incontinence (r=0.73,p=0.001), and greater abdominal pain with flatulence (r=72, p=0.001). Conclusions: Gastrointestinal symptoms are common in SSc regardless of whether they have SIBO. However, a higher Row Score SGI or moderate severe status (NIH PROMIS) correlates with high H scores from the 30th minute, therefore, the questionnaire is useful within the SSc assessment. 
